National University Hospital, Singapore: Carcinoma trials

The registry lists 17 Carcinoma studies with National University Hospital, Singapore as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 1 7Phase 2 10No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• ChemoRT With and Without Dental Stent for Taste Protection in NPC PatientsRecruitingNCT06733948Phase 2
• A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced CancersRecruitingNCT06422403Phase 2
• Single Centre Prospective Evaluation of 68Gallium-FAPI PET/MRI in Hepatocellular CarcinomaRecruitingNCT05687747Phase 1
• Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) and Electrostatic PIPAC (ePIPAC) With Paclitaxel In Patients With Peritoneal CarcinomatosisRecruitingNCT05395910Phase 1
• A Trial of LONSURF in Recurrent/Metastatic Nasopharyngeal CarcinomaStatus unknownNCT04627961Phase 2
• Clinical Trial in RAI-Refractory Thyroid Carcinoma Evaluating BRAF & MEK Blockade for Re-differentiation TherapyStatus unknownNCT04554680Phase 2
• A Biomarker-implemented Clinical Study Evaluating Mutations in MET and TP53 in a Population of Treatment-refractory Squamous Cell CarcinomaStatus unknownNCT04533321Phase 2
• Evaluating Mutations in MET and TP53 Among Patients Diagnosed With Squamous Cell CarcinomaStatus unknownNCT03938012
• Phase 1b of ASLAN001 (Varlitinib) in Patients With Advanced/ Metastatic Hepatocellular Carcinoma (HCC)Status unknownNCT03499626Phase 1/2
• Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) With Oxaliplatin In Patients With Peritoneal CarcinomatosisActive, not recruitingNCT03172416Phase 1
• Reactivating NK Cells in Treating Refractory Head and Neck CancerStatus unknownNCT02507154Phase 1/2
• OPB-51602 in Locally Advanced Nasopharyngeal Carcinoma Prior to Definitive ChemoradiotherapyTerminatedNCT02058017Phase 1
• Study Evaluating Two Loading Regimens of Sunitinib or Bevacizumab Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC)CompletedNCT01309633Phase 2
• Coriolus Versicolor as Palliative Therapy Compared to Placebo in Patients With Child-Pugh C Unresectable Hepatocellular CarcinomaTerminatedNCT01097083Phase 2
• Correlation of the Clinical Behaviour of Renal Cell Carcinoma (RCC) After Debulking Nephrectomy With Tumor Gene Expression in Nephrectomy SpecimensCompletedNCT00718367
• T Regulatory Cells in Renal Cell Carcinoma (PILOT STUDY)CompletedNCT00717743
• A Study Of Nasopharyngeal Carcinoma (NPC) Treated With Celecoxib And ZD1839CompletedNCT00212108Phase 1/2